Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutase-plasmid/liposome (SOD2-PL) gene therapy

Radiation Research

Volumn 155, Issue 1, 2001, Pages 2-14

  Epperly, M W ^a   Gretton, J A ^a   DeFilippi, S J ^a   Sikora, C A ^a   Liggitt, D ^a   Koe, G ^a   Greenberger, J S ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 18; LIPOSOME; MANGANESE SUPEROXIDE DISMUTASE; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DNA DAMAGE; ESOPHAGITIS; ESOPHAGUS STRICTURE; GENE THERAPY; HISTOPATHOLOGY; LONG TERM EXPOSURE; LUNG NON SMALL CELL CANCER; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIATION EXPOSURE; RNA TRANSCRIPTION; THORAX TUMOR;

EID: 0035144389     PISSN: 00337587     EISSN: None     Source Type: Journal    
DOI: 10.1667/0033-7587(2001)155[0002:MORICE]2.0.CO;2     Document Type: Article

References (48)

1. Hyperfractionated radiation therapy with and without concurrent chemotherapy for advanced non-small cell lung cancer
2. Preoperative concomitant cisplatin/VP16 and radiotherapy in stage III non-small cell lung cancer
3. Phase II study of docetaxel and cisplatin in advanced non-small cell lung cancer
4. Radiation and simultaneous cisplatin in non-small cell lung cancer
5. Issues in nonoperative management of locally advanced non-small cell lung cancer
6. Improved survival in stage III non-small cell lung cancer: Seven-year followup of Cancer and Leukemia Group B (CALGB) 8433 trial
7. Effects of concomitant cisplatin and radiotherapy in inoperable non-small cell lung cancer
8. Phase II trial of combination chemotherapy and irradiation in non-small-cell lung cancer, Radiation Therapy Oncology Group 88-04
9. Inoperable non-small cell lung cancer: Radiation with or without chemotherapy
10. Radiotherapy versus radiotherapy enhanced by cisplatin in stage III nonsmall cell lung cancer
11. Phase III trial of thoracic irradiation with or without cisplatin for locally advanced unresectable non-small-cell lung cancer: A Hoosier Oncology Group protocol
12. Randomized trials of radiotherapy alone vs. combined chemotherapy and radiotherapy in stages IIIA and IIIB non-small cell lung cancer: A meta-analysis
13. Concurrent chemoradiation therapy with oral etoposide and cisplatin for locally advanced inoperable non-small-cell lung cancer: Radiation Therapy Oncology Group protocol 91- 06
14. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study
15. Impact of irradiation technique and tumor extent in tumor control and survival of parents with unresectable non-oat cell carcinoma of the lung: Report by the Radiation Therapy Oncology Group
16. Analysis of the influence of elective nodal irradiation on postirradiation pulmonary function
17. Results of Phase II concurrent chemoradiotherapy study using 3-D conformal radiotherapy with cisplatin and oral etoposide in stage III NSCLC
18. The influence of field size and other treatment factors on pulmonary toxicity following hyperfractionated irradiation for inoperable non-small cell lung cancer (NSCLC) - Analysis of a Radiation Therapy Oncology Group (RTOG) protocol
19. Estimation of pneumonitis risk in three-dimensional treatment planning using dose-volume histogram analysis
20. Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy
21. Development of multifield three-dimensional conformal radiotherapy of lung cancer using a total lung dose/volume histogram
22. Length of circumferential esophagus within the high dose radiotherapy field predicts for late esophageal dysfunction
23. Multi-institutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small cell lung cancer
24. Phase II trial of hyperfractionated accelerated radiation therapy for nonresectable non-small cell lung cancer: Results of Eastern Cooperative Oncology Group 4593
25. Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-state small-cell lung cancer
26. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small cell carcinoma of the lung
27. Incorporation of paclitaxel and carboplatin in combinedmodality therapy for locally advanced non-small cell lung cancer
28. Radioprotection of tumor and normal tissues by thiophosphate compounds
29. Radiation pathology and the clinical response of lung and esophagus
30. Time-lose relationships in the mouse esophagus
31. Results of multifield conformal radiation therapy of NSCLC using multileaf collimation beams
32. Protection against late effects of radiation by S-2-(3-aminopropylamino)-ethylphosphorothioic acid
33. Transport of aminothiol radioprotectors into mammalian cells: Passive diffusion versus mediated uptake
34. Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis
35. Prevention of late effects of irradiation lung damage bY manganese superoxide dismutase gene therapy
36. MnSOD-PL pulmonary radioprotective gene therapy: Modulation of irradiation-induced mRNA for IL-1, TNF-α, and TGF-β correlates with delay of organizing alveolitis/fibrosis
37. Prevention of irradiation-induced esophagitis by intraesophageal plasmid/liposome delivery of the human manganese superoxide dismutase (MnSOD) transgene
38. Intratracheal injection of manganese superoxide dismutase (MnSOD) plasmid/liposomes protects normal lung but not orthotopic tumors from irradiation
39. 1/S cell cycle arrest
40. Plasmid/liposome transfer of the human manganese superoxide dismutase (MnSOD) transgene prevents ionizing irradiation-induced apoptosis in human esophagus Organ explant culture
41. Expression of transfected recombinant oncogenes increases radiation resistance of clonal hematopoietic and fibroblast cell lines selectively at clinical low dose rate
42. Difficulty swallowing due to narrowing of the esophagus has many causes, both benign and malignant
43. The effect of radiation on the esophagus
44. Radiological manifestations of radiation-induced injury to the normal upper gastrointestinal tract
45. Superoxide dismutase and pulmonary oxygen toxicity
46. The role of cellular glutathione peroxidase redox regulation in the suppression of tumor cell growth by manganese superoxide dismutase